Jazz Pharma Consensus Deemed Low and 4 Stock Analyses Making Rounds

Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ): Current Price: $56.57

According to Lazard Capital, consensus expectations for Jazz Pharmaceuticals have been too low after the company’s Xyrem price increase last week. The firm reiterates its Buy rating and an $87 price target on the stock.

Investors are making great returns as markets roar higher. Join the party. Click here to discover our Feature Stock Pick now!